Sökning: "Prognostic Factors in Non-Small Cell Lung Cancer NSCLC"
Visar resultat 1 - 5 av 6 avhandlingar innehållade orden Prognostic Factors in Non-Small Cell Lung Cancer NSCLC.
1. Angiogenesis Related Markers In Non-Small Cell Lung Cancer
Sammanfattning : This thesis investigated the predictive and the prognostic powers of angiogenesis related markers in both operable and inoperable non-small cell lung cancer (NSCLC) patients.In the first and second study, we investigated the serological fractions of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in 2 cohorts of patients with either operable or inoperable NSCLC. LÄS MER
2. Prognostic Factors in Non-Small Cell Lung Cancer (NSCLC)
Sammanfattning : Background: Non-small cell lung cancer (NSCLC) is the cancer disease with the highest mortality globally. About 75% of NSCLC patients are diagnosed in an advanced stage where surgical treatment is not possible. For patients with locally advanced disease without distant metastases, the treatment of choice is curatively intended radiotherapy. LÄS MER
3. LRIG1 in lung cancer : prognostic effects and mechanistic studies
Sammanfattning : Lung cancer is the leading cause of cancer-related death worldwide as well as in Sweden. Non-small cell lung cancer (NSCLC) is the predominant form, which is largely subdivided into adenocarcinomas and squamous cell carcinomas. LÄS MER
4. Biomarkers for CNS metastasis in non-small cell lung cancer (NSCLC)
Sammanfattning : Non-small cell lung cancer (NSCLC) comprises more than 75% of lung cancer cases and is usually diagnosed in advanced stages. Lung cancer is the leading cause of cancer death among all solid tumours and the second most common malignancy globally. LÄS MER
5. Clinical Aspects of Inflammation in Non-small Cell Lung Cancer
Sammanfattning : Lung cancer is the most common cause of cancer death worldwide, with about 1.2 million deaths every year. In Sweden, about 3500 new cases are diagnosed every year. The majority of patients presents with advanced non-small cell lung cancer (NSCLC) and is treated with palliative intent. LÄS MER